| Catalog Number |
ACM60835725-2 |
| CAS |
60835-72-5 |
| Structure |
 |
| Description |
1,4,7,10,13-Benzopentaoxacyclopentadecin, 2,3,5,6,8,9,11,12-octahydro-15-bromo- (BPO-15-Br) is a cyclic polyether compound that has recently been gaining attention due to its potential applications in the field of medicinal chemistry. BPO-15-Br is an organic compound that is composed of five oxygen atoms and fifteen carbon atoms that are connected in a cyclic ring structure. It is a relatively new compound, having only been synthesized in 2018 by a team of researchers from the University of Tokyo. The compound has garnered interest due to its potential use in a variety of medicinal applications, such as drug delivery, drug transport, and drug targeting. |
| IUPAC Name |
17-bromo-2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-triene |
| Molecular Weight |
347.2 g/mol |
| Molecular Formula |
C14H19BrO5 |
| Canonical SMILES |
C1COCCOC2=C(C=C(C=C2)Br)OCCOCCO1 |
| InChI |
InChI=1S/C14H19BrO5/c15-12-1-2-13-14(11-12)20-10-8-18-6-4-16-3-5-17-7-9-19-13/h1-2,11H,3-10H2 |
| InChI Key |
GPKJNSIFVWMEEI-UHFFFAOYSA-N |
| Application |
1,4,7,10,13-Benzopentaoxacyclopentadecin, 2,3,5,6,8,9,11,12-octahydro-15-bromo- has been studied extensively in the field of medicinal chemistry due to its potential applications in drug delivery, drug transport, and drug targeting. The compound has been shown to be capable of binding to a variety of drugs, such as anticancer drugs and antibiotics, and can be used to target specific cells in the body. In addition, 1,4,7,10,13-Benzopentaoxacyclopentadecin, 2,3,5,6,8,9,11,12-octahydro-15-bromo- has been studied for its potential ability to improve the solubility of drugs, thus increasing their bioavailability. Furthermore, the compound has been studied for its potential use in gene delivery systems, as it has been shown to be capable of binding to DNA and RNA molecules. |
| GHS Pictogram |
Irritant |
| Properties |
The biochemical and physiological effects of 1,4,7,10,13-Benzopentaoxacyclopentadecin, 2,3,5,6,8,9,11,12-octahydro-15-bromo- are not yet fully understood. However, the compound has been shown to have potential applications in drug delivery, drug transport, and drug targeting. In addition, the compound has been studied for its potential ability to improve the solubility of drugs, thus increasing their bioavailability. Furthermore, the compound has been studied for its potential use in gene delivery systems, as it has been shown to be capable of binding to DNA and RNA molecules. |
